Chapter/Section Purchase

1 Introduction to Research & Analysis Reports
1.1 Artificial Blood Cells Market Definition
1.2 Market Segments
1.2.1 Market by Source
1.2.2 Market by Application
1.3 Global Artificial Blood Cells Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Artificial Blood Cells Overall Market Size
2.1 Global Artificial Blood Cells Market Size: 2021 VS 2028
2.2 Global Artificial Blood Cells Revenue, Prospects & Forecasts: 2017-2028
2.3 Global Artificial Blood Cells Sales: 2017-2028
3 Company Landscape
3.1 Top Artificial Blood Cells Players in Global Market
3.2 Top Global Artificial Blood Cells Companies Ranked by Revenue
3.3 Global Artificial Blood Cells Revenue by Companies
3.4 Global Artificial Blood Cells Sales by Companies
3.5 Global Artificial Blood Cells Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 Artificial Blood Cells Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers Artificial Blood Cells Product Type
3.8 Tier 1, Tier 2 and Tier 3 Artificial Blood Cells Players in Global Market
3.8.1 List of Global Tier 1 Artificial Blood Cells Companies
3.8.2 List of Global Tier 2 and Tier 3 Artificial Blood Cells Companies
4 Sights by Product
4.1 Overview
4.1.1 By Source - Global Artificial Blood Cells Market Size Markets, 2021 & 2028
4.1.2 Animal Hemoglobin
4.1.3 Human Hemoglobin
4.1.4 Stem Cell
4.1.5 Others
4.2 By Source - Global Artificial Blood Cells Revenue & Forecasts
4.2.1 By Source - Global Artificial Blood Cells Revenue, 2017-2022
4.2.2 By Source - Global Artificial Blood Cells Revenue, 2023-2028
4.2.3 By Source - Global Artificial Blood Cells Revenue Market Share, 2017-2028
4.3 By Source - Global Artificial Blood Cells Sales & Forecasts
4.3.1 By Source - Global Artificial Blood Cells Sales, 2017-2022
4.3.2 By Source - Global Artificial Blood Cells Sales, 2023-2028
4.3.3 By Source - Global Artificial Blood Cells Sales Market Share, 2017-2028
4.4 By Source - Global Artificial Blood Cells Price (Manufacturers Selling Prices), 2017-2028
5 Sights By Application
5.1 Overview
5.1.1 By Application - Global Artificial Blood Cells Market Size, 2021 & 2028
5.1.2 Cardiovascular Diseases
5.1.3 Anemia
5.1.4 Organ Transplant
5.1.5 Others
5.2 By Application - Global Artificial Blood Cells Revenue & Forecasts
5.2.1 By Application - Global Artificial Blood Cells Revenue, 2017-2022
5.2.2 By Application - Global Artificial Blood Cells Revenue, 2023-2028
5.2.3 By Application - Global Artificial Blood Cells Revenue Market Share, 2017-2028
5.3 By Application - Global Artificial Blood Cells Sales & Forecasts
5.3.1 By Application - Global Artificial Blood Cells Sales, 2017-2022
5.3.2 By Application - Global Artificial Blood Cells Sales, 2023-2028
5.3.3 By Application - Global Artificial Blood Cells Sales Market Share, 2017-2028
5.4 By Application - Global Artificial Blood Cells Price (Manufacturers Selling Prices), 2017-2028
6 Sights by Region
6.1 By Region - Global Artificial Blood Cells Market Size, 2021 & 2028
6.2 By Region - Global Artificial Blood Cells Revenue & Forecasts
6.2.1 By Region - Global Artificial Blood Cells Revenue, 2017-2022
6.2.2 By Region - Global Artificial Blood Cells Revenue, 2023-2028
6.2.3 By Region - Global Artificial Blood Cells Revenue Market Share, 2017-2028
6.3 By Region - Global Artificial Blood Cells Sales & Forecasts
6.3.1 By Region - Global Artificial Blood Cells Sales, 2017-2022
6.3.2 By Region - Global Artificial Blood Cells Sales, 2023-2028
6.3.3 By Region - Global Artificial Blood Cells Sales Market Share, 2017-2028
6.4 North America
6.4.1 By Country - North America Artificial Blood Cells Revenue, 2017-2028
6.4.2 By Country - North America Artificial Blood Cells Sales, 2017-2028
6.4.3 US Artificial Blood Cells Market Size, 2017-2028
6.4.4 Canada Artificial Blood Cells Market Size, 2017-2028
6.4.5 Mexico Artificial Blood Cells Market Size, 2017-2028
6.5 Europe
6.5.1 By Country - Europe Artificial Blood Cells Revenue, 2017-2028
6.5.2 By Country - Europe Artificial Blood Cells Sales, 2017-2028
6.5.3 Germany Artificial Blood Cells Market Size, 2017-2028
6.5.4 France Artificial Blood Cells Market Size, 2017-2028
6.5.5 U.K. Artificial Blood Cells Market Size, 2017-2028
6.5.6 Italy Artificial Blood Cells Market Size, 2017-2028
6.5.7 Russia Artificial Blood Cells Market Size, 2017-2028
6.5.8 Nordic Countries Artificial Blood Cells Market Size, 2017-2028
6.5.9 Benelux Artificial Blood Cells Market Size, 2017-2028
6.6 Asia
6.6.1 By Region - Asia Artificial Blood Cells Revenue, 2017-2028
6.6.2 By Region - Asia Artificial Blood Cells Sales, 2017-2028
6.6.3 China Artificial Blood Cells Market Size, 2017-2028
6.6.4 Japan Artificial Blood Cells Market Size, 2017-2028
6.6.5 South Korea Artificial Blood Cells Market Size, 2017-2028
6.6.6 Southeast Asia Artificial Blood Cells Market Size, 2017-2028
6.6.7 India Artificial Blood Cells Market Size, 2017-2028
6.7 South America
6.7.1 By Country - South America Artificial Blood Cells Revenue, 2017-2028
6.7.2 By Country - South America Artificial Blood Cells Sales, 2017-2028
6.7.3 Brazil Artificial Blood Cells Market Size, 2017-2028
6.7.4 Argentina Artificial Blood Cells Market Size, 2017-2028
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Artificial Blood Cells Revenue, 2017-2028
6.8.2 By Country - Middle East & Africa Artificial Blood Cells Sales, 2017-2028
6.8.3 Turkey Artificial Blood Cells Market Size, 2017-2028
6.8.4 Israel Artificial Blood Cells Market Size, 2017-2028
6.8.5 Saudi Arabia Artificial Blood Cells Market Size, 2017-2028
6.8.6 UAE Artificial Blood Cells Market Size, 2017-2028
7 Manufacturers & Brands Profiles
7.1 Dextro-Sang Corporation
7.1.1 Dextro-Sang Corporation Corporate Summary
7.1.2 Dextro-Sang Corporation Business Overview
7.1.3 Dextro-Sang Corporation Artificial Blood Cells Major Product Offerings
7.1.4 Dextro-Sang Corporation Artificial Blood Cells Sales and Revenue in Global (2017-2022)
7.1.5 Dextro-Sang Corporation Key News
7.2 BioPure Corporation
7.2.1 BioPure Corporation Corporate Summary
7.2.2 BioPure Corporation Business Overview
7.2.3 BioPure Corporation Artificial Blood Cells Major Product Offerings
7.2.4 BioPure Corporation Artificial Blood Cells Sales and Revenue in Global (2017-2022)
7.2.5 BioPure Corporation Key News
7.3 Sangart
7.3.1 Sangart Corporate Summary
7.3.2 Sangart Business Overview
7.3.3 Sangart Artificial Blood Cells Major Product Offerings
7.3.4 Sangart Artificial Blood Cells Sales and Revenue in Global (2017-2022)
7.3.5 Sangart Key News
7.4 Northfield Laboratories
7.4.1 Northfield Laboratories Corporate Summary
7.4.2 Northfield Laboratories Business Overview
7.4.3 Northfield Laboratories Artificial Blood Cells Major Product Offerings
7.4.4 Northfield Laboratories Artificial Blood Cells Sales and Revenue in Global (2017-2022)
7.4.5 Northfield Laboratories Key News
7.5 Baxter International
7.5.1 Baxter International Corporate Summary
7.5.2 Baxter International Business Overview
7.5.3 Baxter International Artificial Blood Cells Major Product Offerings
7.5.4 Baxter International Artificial Blood Cells Sales and Revenue in Global (2017-2022)
7.5.5 Baxter International Key News
7.6 Dentritech
7.6.1 Dentritech Corporate Summary
7.6.2 Dentritech Business Overview
7.6.3 Dentritech Artificial Blood Cells Major Product Offerings
7.6.4 Dentritech Artificial Blood Cells Sales and Revenue in Global (2017-2022)
7.6.5 Dentritech Key News
7.7 FluorO2 Therapeutics
7.7.1 FluorO2 Therapeutics Corporate Summary
7.7.2 FluorO2 Therapeutics Business Overview
7.7.3 FluorO2 Therapeutics Artificial Blood Cells Major Product Offerings
7.7.4 FluorO2 Therapeutics Artificial Blood Cells Sales and Revenue in Global (2017-2022)
7.7.5 FluorO2 Therapeutics Key News
7.8 Nuvox Pharma
7.8.1 Nuvox Pharma Corporate Summary
7.8.2 Nuvox Pharma Business Overview
7.8.3 Nuvox Pharma Artificial Blood Cells Major Product Offerings
7.8.4 Nuvox Pharma Artificial Blood Cells Sales and Revenue in Global (2017-2022)
7.8.5 Nuvox Pharma Key News
7.9 Alpha Therapeutic Corporation
7.9.1 Alpha Therapeutic Corporation Corporate Summary
7.9.2 Alpha Therapeutic Corporation Business Overview
7.9.3 Alpha Therapeutic Corporation Artificial Blood Cells Major Product Offerings
7.9.4 Alpha Therapeutic Corporation Artificial Blood Cells Sales and Revenue in Global (2017-2022)
7.9.5 Alpha Therapeutic Corporation Key News
7.10 HemoBioTech
7.10.1 HemoBioTech Corporate Summary
7.10.2 HemoBioTech Business Overview
7.10.3 HemoBioTech Artificial Blood Cells Major Product Offerings
7.10.4 HemoBioTech Artificial Blood Cells Sales and Revenue in Global (2017-2022)
7.10.5 HemoBioTech Key News
8 Global Artificial Blood Cells Production Capacity, Analysis
8.1 Global Artificial Blood Cells Production Capacity, 2017-2028
8.2 Artificial Blood Cells Production Capacity of Key Manufacturers in Global Market
8.3 Global Artificial Blood Cells Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Artificial Blood Cells Supply Chain Analysis
10.1 Artificial Blood Cells Industry Value Chain
10.2 Artificial Blood Cells Upstream Market
10.3 Artificial Blood Cells Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Artificial Blood Cells Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer